NIH-funded research R21 grant

Massively parallel test of brain gene switches in fentanyl-exposed mice

Official title: In vivo massive parallel reporter assay to analyze the function of cis-regulatory elements and variants implicated in substance use disorders

Funded at University of California, San Diego · NIH-11397239 · Data updated 2026-11-12

Researchers will test how specific genetic switches in the brain respond after chronic fentanyl exposure, using a new high-throughput method in live mice.

More Substance Use research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startSeptember 1, 2025
Project endAugust 31, 2027
Funding year2026
Award (this year)$196,726
NIH project number5R21DA060455-02
Project IDNIH-11397239 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with substance use disorders or those at risk could benefit from future therapies informed by understanding brain regulatory elements.

Less likely to help

This basic science study does not involve patient participation or direct treatment.

What this research studies

This project will use a cutting-edge MPRA approach to measure how candidate regulatory DNA elements behave in mouse brain tissue after chronic fentanyl exposure. By comparing activity at a paired-TSS-MPRA design, scientists aim to map which regulatory regions drive gene activity related to addiction. The study will be conducted in primary neurons and brain tissues of mice to ensure relevance to brain function in addiction. If successful, this method could reveal how human genetic variants influence the brain’s response to opioids in a living system.

Why it matters

Potential benefit: Insights from this work could help identify brain gene regulators linked to opioid use disorders, guiding future therapies or personalized risk assessments.

How similar studies have gone: This approach builds on prior MPRA work and aims to extend it to in vivo brain tissue in a substance-use context, with promising potential per past high-throughput regulatory assays.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Telese, Francesca — University of California, San Diego
  • Study coordinator: Telese, Francesca

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.